PulseCX

211 B Progress Drive

Montgomeryville, PA 18936

Telephone 

215-699-9200

Website 

pulsecx.com

 

QUICK FACTS

Accounts

Account wins 3

Active business clients 8

Brands by 2020 sales

Brand-product accounts held 9

$25 million or less 1

$50 million-$100 million 1

$100 million-$500 million 3

$500 million-$1 billion 2

Products not yet approved/launched 2

 

CLIENT ROSTER

BioDelivery Sciences International

Enalare Therapeutics 

Ferring

Medexus

Mitsubishi Tanabe Pharma

Reckitt Benckiser 

Valensa International 

 

2021 marks the agency’s 40th anniversary as an innovative, independent marketing communications company, dedicated to providing clients with strategy, creative, technology, and analytics that deliver success. “Leveraging our rich history in direct response and customer relationship marketing, PulseCX focuses on creating customer experiences (CXs) that engage and change the behavior of healthcare professionals (HCPs), patients, and caregivers,” management says. 

“Of course, this past year has been a unique experience for all of us,” agency executives say. “Like everyone, we’ve adapted to working from home; we’re now proficient at Zoom, Teams, and Webex; we interact with our clients (and each other) over laptop monitors, and accept that virtual happy hours are our way to connect out of the office. But we miss each other’s company; we can’t wait to get back to the office and be with each other in person – it’s the bond that makes us stronger.”

Although every company has a culture, “At PulseCX, we’ll stack ours up against any other place of business. It’s the living, breathing attitude expressed by people who have each other’s backs every day. Our culture is all about natural respect and collaboration. It’s a shared bond that makes us work stronger together. We trust each other, and that makes each work day all the more productive and enjoyable for us.”

PulseCX does not have an open-door policy, according to the leadership team. “We have a no-door policy,” they say. “Every desk is located in one common space. Hardwood floors, hanging chairs, video screens, and comfortable couches create a more relaxed environment to conduct meetings, host client presentations, brainstorm ideas, or share lunch with a coworker. Community workspaces are the norm, along with solitude spaces for when we need to hear our own thoughts clearly.” 

RECENT ACCOMPLISHMENTS

For several years, PulseCX has partnered with Mitsubishi Tanabe Pharma America (MTPA) to create, manage, and optimize all multichannel marketing (MCM) efforts for Radicava (edaravone). 

“Patients with amyotrophic lateral sclerosis (ALS) struggle to make sense of this terminal disease; they’re searching for education, support, resources, and a sense of connection with others who have experienced the same diagnosis,” agency executives explain. “In partnership with PulseCX, MTPA helps meet the complex and individual needs of patients, caregivers, and HCPs across multiple channels of communication. From in-home personal support to digital connectivity that provides access to a wide array of information, services, and peer-group experiences, the brand creates unique, positive experiences for ALS patients, caregivers, and HCPs to help them navigate their difficult journeys.” 

According to agency leaders, based on the success of these efforts, MTPA has expanded its partnership with PulseCX to include upcoming line extensions and its new brand Exservan.

PulseCX also maintains a longstanding relationship with Medexus Pharmaceuticals to create and manage all marketing communications for Ixinity [coagulation factor IX (recombinant)]. 

“Adults with hemophilia B are often overlooked by the healthcare system, which targets most of its resources and services to newly-diagnosed pediatric patients,” management says. “As a result, adult patients often reach out to each other to share experiences and gather information about disease management and treatment options.”

Agency leaders say, “Having supported the pre-launch and launch efforts of the brand, PulseCX continues to create and facilitate these positive patient experiences, working with real patients to create real stories that resonate with patients and HCPs in real time. These real patient ‘IXperiences’ are featured in all aspects of our marketing communications to help deliver core messaging during key moments of impact. Delivered by the Ixinity Ambassadors in diverse formats across multiple channels, these communications engage our target audience and prompt them to experience Ixinity for themselves.

BioDelivery Sciences International (BDSI) tapped PulseCX to help the company create a new corporate identity that showcases advanced therapies such as Belbuca (buprenorphine). These products are designed to give patients living with serious and debilitating chronic conditions the opportunity to make the most of their lives. “One of the core tenets of their patients’ CX is that serious and debilitating chronic conditions are complex and often misunderstood, which can leave patients feeling isolated and alone,” agency executives say. “That’s why BDSI marketing communications are designed specifically to reach out and advocate for their patient communities as an important part of driving therapeutic solutions.”

The agency has added several new clients over the past year as well. Reckitt Benckiser awarded PulseCX the global medical marketing agency of record (AOR) for its infant nutrition allergy franchise, including Nutramigen LGG and Puramino. “Pediatricians around the globe too often focus only on treating the short-term symptoms of cow’s milk allergy (CMA), ignoring the fact that CMA is a clinical marker of longer-term issues associated with a child’s immune response,” management says. “They perceive most products in the category to be virtually the same, basing their recommendations on non-clinical preferences such as taste and cost.” PulseCX recently developed the global “Domino Campaign” to help differentiate Nutramigen LGG and highlight its clinical superiority in preventing longer-term allergic manifestations, such as asthma and eczema. The campaign will be executed worldwide to increase Nutramigen LGG recommendations and competitive market share.

Enalare Therapeutics is a privately owned clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions. In 2020, the company named PulseCX the AOR for its lead drug candidate, ENA-001, a patent-protected new chemical entity (NCE) beginning pivotal clinical trials in the United States. 

“With its novel mechanism-of-action (MOA) and demonstrated safety and efficacy profile, ENA-001 holds the potential to dramatically improve the lives of those impacted by several of the top health emergencies in the U.S., including the drug-overdose epidemic and COVID-19 pandemic,” PulseCX executives say. “ENA-001 will offer new treatment options for physicians, emergency responders, and caregivers to address respiratory depression across multiple settings.”

According to PulseCX, Valensa International tapped into the agency’s CX-marketing expertise to help define the unmet needs and motivations for Urologists to recommend their dietary supplement Flomentum (serenoa repens pure oil extract) for the treatment of mild-to-moderate benign prostatic hyperplasia (BPH). Flomentum is a unique extract of saw palmetto that has been clinically proven to reduce urinary symptoms and promote healthy urinary and prostate function, and is the first and only prostate health supplement to be verified by the United States Pharmacopeia (USP), providing an important Rx alternative for patients with BPH. 

As AOR for sales and marketing communications, PulseCX is working as an extension of Valensa’s marketing team to help make Flomentum the No. 1 expert-recommended, consumer-preferred supplement brand in prostate health, agency leaders say.

David Zaritsky, CEO

STRUCTURE AND SERVICES

To create the optimal CX, the agency first defines the customer journey (behaviorally and attitudinally) and identifies the key moments of impact where the target audience is more likely to engage with the messaging and connect with the data/science that embodies their reasons to believe (RTBs), according to agency executives. 

“In addition, key insights from CX mapping allow us to define each audience segment and the hero journey that defines ‘what’s in it for them,’ so we’re able to customize messaging that specifically resonates with the emotional drivers behind their decision making,” agency leaders say.

Throughout the customer’s journey, PulseCX delivers customized communications at each moment of impact, and track and measure all actions triggered by each communication. “The predefined key performance indicators (KPIs) and embedded analytics allow us to assess effectiveness in real time and customize our communications on an iterative basis,” management says. “By knowing what works and, more importantly, what doesn’t work, we’re able to optimize our clients’ marketing communications to achieve, and frequently exceed, target ROIs.”